Johnson & Johnson MecTech says it has received US Food and Drug Administration 510(k) clearance for its first robotic-assisted platform for spine, targeting a commercial launch in the first half of 2025.
J&J To Launch Velys Spine Platform After Securing FDA Clearance
J&J Medtech announced the FDA clearance of its dual-use robotics platform Velys Spine with plans to go to market in the first half of 2025.
